Brand Manager Orforglipron at Eli Lilly and Company

Lisbon, Lisbon, Portugal

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

University degree
MBA
3 years of marketing related experience
Experience with brand management
Omnichannel marketing experience
Teamwork and leadership – Proven ability to partner with and engage others towards a common goal
Strong track record of marketing, medical and/or sales successes and strong organizational skills
Experimentation and Risk Taking – Proven track record of pursuing non-conventional ways to meet customer needs and enhance the customer experience
Learning agility and high comfort with change in a high-stake environment
Project Management – Ability to manage detailed, complex projects
Business acumen skills – budget management, strategic trade-offs, development and monitoring of lead measures
Excellent interpersonal, written, and verbal communication skills
Proficient computer skills and AI
Portuguese and English languages
Location: Lisbon

Responsibilities

Driving the strategic development and implementation of Orforglipron in CWM and Diabetes
Informing and supporting continued transformation agenda and institutionalizing commercial shifts necessary to successfully deliver on the CWM and Diabetes strategy
Gaining deep customer insights across patients, payers and HCPs to inform brand strategy in a rapidly evolving market
Creating and executing a plan to engage patients and HCPs, including developing marketing strategies and working with teams to align priorities and ensure successful implementation that drives growth
Leadership of the customer planning process and operational plan process
Partnering with the Global, IBU and HUB teams to ensure alignment on strategy and efficient use of common resources
Partnering with Mounjaro team to ensure alignment on strategy and efficient use of common resources
Driving and leading the launch preparation partnership process in collaboration with the cross functional local and global teams
Managing of the overall commercial brand budget for pre and post launch
Driving innovative thinking across the cross functional team for a bold and comprehensive pre and post launch OCE plans
Operates with high integrity, complies with Lilly policies and procedures, external legal and compliance requirements
Willing to spend time meeting customers to develop external relationships

Skills

Brand Management

Launch Planning

Go to Market Strategy

Customer Insights

Thought Leader Engagement

Marketing Strategy

Cross Functional Collaboration

Strategic Planning

HCP Engagement

Payer Strategy

Diabetes

Chronic Weight Management

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free